Induced Expression of Cytochrome P450 1A and NAD(P)H:Quinone Oxidoreductase Determined at mRNA, Protein, and Enzyme Activity Levels in Rats Exposed to the Carcinogenic Azo Dye 1-Phenylazo-2-naphthol (Sudan I)

2013 ◽  
Vol 26 (2) ◽  
pp. 290-299 ◽  
Author(s):  
Marie Stiborová ◽  
Helena Dračínská ◽  
Václav Martínek ◽  
Dagmar Svášková ◽  
Petr Hodek ◽  
...  
1989 ◽  
Vol 121 (3) ◽  
pp. 374-382 ◽  
Author(s):  
Donald C. Johnson ◽  
Mitra Sen

Abstract. The in vivo regulatory action of LH on the ovarian androgen synthesizing enzyme cytochrome P45017α (17α-hydroxylase/C17, 20-lyase) was studied in cyclic golden hamsters. Immunohistochemical studies using anti-porcine testicular cytochrome P45017α antibody indicated that the enzyme was limited to thecal cells. Transient removal of the negative feedback action of endogenous steroids by use of aminoglutethimide phosphate produced an increase in endogenous gonadotropins. A single dose (30 mg) of aminoglutethimide on days 1, 2 or 3 of the estrous cycle (day 1 = estrus), increased serum levels of LH, but only for about 12 h. Increases in enzyme activities, which persisted for at least 24 h, followed. Two doses of aminoglutethimide, 12 h apart, maintained elevated levels of serum LH for about 36 h, and enzyme activites for at least 48 h. However, when the drug was given after the pre-ovulatory surge of LH on proestrus, and again on the morning of estrus, neither serum LH nor enzyme activity levels increased within 24 h. Induced increases in enzyme activity had no effect upon ovulation rate, as determined by the number of oviductal eggs present on the morning of estrus. The results demonstrate clearly a close correlation between serum concentrations of LH and ovarian androgen synthesizing enzyme activity.


2012 ◽  
Vol 124-125 ◽  
pp. 106-113 ◽  
Author(s):  
Tarquin Dorrington ◽  
Juliano Zanette ◽  
Flávia L. Zacchi ◽  
John J. Stegeman ◽  
Afonso C.D. Bainy

2015 ◽  
Vol 15 (8) ◽  
pp. 829-840 ◽  
Author(s):  
Marie Stiborova ◽  
Heinz Schmeiser ◽  
Eva Frei ◽  
Petr Hodek ◽  
Vaclav Martinek
Keyword(s):  
Azo Dye ◽  

2021 ◽  
Vol 7 (2) ◽  
pp. 28
Author(s):  
Camille S. Corre ◽  
Dietrich Matern ◽  
Joan E. Pellegrino ◽  
Carlos A. Saavedra-Matiz ◽  
Joseph J. Orsini ◽  
...  

Krabbe disease (KD) is a rare inherited neurodegenerative disorder caused by a deficiency in galactocerebrosidase enzyme activity, which can present in early infancy, requiring an urgent referral for hematopoietic stem cell transplantation, or later in life. Newborn screening (NBS) for KD requires identification and risk-stratification of patients based on laboratory values to predict disease onset in early infancy or later in life. The biomarker psychosine plays a key role in NBS algorithms to ascertain probability of early-onset disease. This report describes a patient who was screened positive for KD in New York State, had a likely pathogenic genotype, and showed markedly reduced enzyme activity but surprisingly low psychosine levels. The patient ultimately developed KD in late infancy, an outcome not clearly predicted by existing NBS algorithms. It remains critical that psychosine levels be evaluated alongside genotype, enzyme activity levels, and the patient’s evolving clinical presentation, ideally in consultation with experts in KD, in order to guide diagnosis and plans for monitoring.


2009 ◽  
Vol 28 (3) ◽  
pp. 370-378 ◽  
Author(s):  
Susanne Rudzok ◽  
Eike Schmücking ◽  
Carolin Graebsch ◽  
Olf Herbarth ◽  
Mario Bauer

Sign in / Sign up

Export Citation Format

Share Document